glucuronic acid has been researched along with capecitabine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbari Javar, H; Farjam, AS; Ibrahim Noordin, M; Kadivar, A; Kamalidehghan, B; Taghizadeh Davoudi, E | 1 |
| Adena, SKR; Mishra, B; Pandey, S; Upadhyay, M; Vardhan, H | 1 |
| Ganesh, M; Jang, HT; Rathnam, G; Sinha, P; Udhumansha, U | 1 |
| Cheruku, SP; Day, CM; Gadag, S; Garg, S; Kumar, N; Manandhar, S; Mehta, CH; Narayan, R; Nayak, UY; Nayak, Y; Pai, KSR; Raichur, AM; Suresh, A | 1 |
4 other study(ies) available for glucuronic acid and capecitabine
| Article | Year |
|---|---|
Preparation and characterization of a gastric floating dosage form of capecitabine.
Topics: Acrylic Resins; Alginates; Breast Neoplasms; Capecitabine; Chemistry, Pharmaceutical; Deoxycytidine; Drug Dosage Calculations; Female; Fluorouracil; Gastrointestinal Diseases; Glucuronic Acid; Hexuronic Acids; Humans; Hypromellose Derivatives; Methylcellulose; Sodium Bicarbonate; United States; United States Food and Drug Administration | 2013 |
Development and optimization of locust bean gum and sodium alginate interpenetrating polymeric network of capecitabine.
Topics: Alginates; Capecitabine; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Galactans; Glucuronic Acid; Hexuronic Acids; Mannans; Particle Size; Plant Gums; Polymers | 2018 |
Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation.
Topics: Alginates; Animals; Capecitabine; Capsules; Cecum; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Rats; Temperature | 2018 |
Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Topics: Animals; Capecitabine; Cell Line, Tumor; Cell Survival; Chitosan; Coated Materials, Biocompatible; Colorectal Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Glucuronic Acid; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Porosity; Rats; Rats, Wistar; Silicon Dioxide; Xenograft Model Antitumor Assays | 2021 |